Controlled Substances - As introduced, requires the commissioner of health, in consultation with the commissioner of mental health and substance abuse services, to study and report to the health committee of the house of representatives and the health and welfare committee of the senate, on or before January 15, 2018, concerning any recommended changes to prescribing guidelines for buprenorphine products, or to Tennessee Code Annotated, Section 53-11-311. - Amends TCA Title 53, Chapter 11, Part 3.
Bill status
in committee
1 of 4 stages cleared
Introduction
Feb 2017
Committee Review
Floor Vote
Governor
Introduced Feb 9, 2017
Last action Feb 15, 2017
Floor votes
How they voted
No floor votes recorded yet.
Full legislative history
Actions timeline
Total actions
8
Key actions
1
Committee
3
Feb 15, 2017
Committee
P2C, ref. to Health Committee
lower
Feb 15, 2017
Committee
Assigned to s/c Health Subcommittee
lower
Feb 13, 2017
Upper · Passed
Passed on Second Consideration, refer to Senate Health and Welfare Committee
upper
Feb 9, 2017
Introduced
Filed for intro.
lower
Feb 9, 2017
Introduced
Intro.
lower
Feb 9, 2017
Introduced
Filed for introduction
upper
Feb 9, 2017
Introduced
Introduced, Passed on First Consideration
upper
2 primary · 0 co-sponsors
Sponsors
Ask Maddy
·
AI policy assistant
Ask Maddy about SB 1323
Scope: TN
Hi! I can help you understand SB 1323. What would you like to know?
Try one of these
i
Maddy answers using official bill text and legislative records. Always verify before sharing.
Sources cited inline